Morten Karsdal
Chief Executive Officer
Biotechnology
Nordic Bioscience A/S
Denmark
Biography
Education: M.Sc., Cell and Molecular Biology University of Southern Denmark - Ph.D., Bone and Cartilage Pharmacology AVT Business School - mMBA, Certificate in Applied Management Harvard Business School - Leading the Virtual Company and Essential Leader Program Morten Karsdal joined Nordic Bioscience in 2001 and has been CEO of Nordic Bioscience A/S since June 2010. Since 2002, Morten Karsdal has focused his research on the discovery and development of novel biochemical markers. This has resulted in the development of more than 60 ELISA assays for detecting biomarkers that have been used for research in the fields of fibrosis, osteoporosis and osteoarthritis. One of these assays has been 510(k) approved by the Food and Drug Administration (FDA) in the USA. Morten Karsdal has published more than 327 peer-reviewed articles in leading journals and has an H-factor of 58 (MAY 2017).
Research Interest
Biotechnology Biochemistry Biopharmaceutical
